CrowdStrike To Rally Around 18%? Here Are 10 Top Analyst Forecasts For Friday - CrowdStrike Holdings (NAS

Analysts updated price targets for several companies. Needham raised CrowdStrike's (CRWD) target to $310, Baird increased Humana's (HUM) to $596, and others adjusted targets for Robinhood (HOOD), Webull (BULL), Align (ALGN), Pacira (PCRX), Sailpoint (SAIL), Unity (U), and Arcturus (ARCT). AT&T's (T) target was cut by Scotiabank.

Original reporting
Published Oct 9, 2026, 1:11 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 9, 2026, 2:32 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefFinancial news
Primary signal
$HOOD
Bullish
medium confidence
Mentioned
$HOOD · $BULL · $ALGN · $PCRX · $SAIL · $U
Relevance
4/10
AlphAI data visualization · based on benzinga.com
Decision brief

The 30-second read

$HOODBullishLow
01

Why it matters

The revisions provide modest trading cues but lack a fresh catalyst, limiting actionable opportunities.

02

Market read

Target updates affect individual stock sentiment but do not drive sector-wide moves.

03

What to watch

No new fundamental data released; revisions reflect analyst sentiment rather than company performance.

Relevance 4/10Novelty 4/10Timing: today

Background

Analyst firms updated price targets and ratings for a set of U.S.-listed companies following recent market activity.

Company-level read

Ticker impact

$HOODBullishMedium confidence
Context

Morgan Stanley raised price target to $160, indicating potential upside.

Expected impact

likely upward pressure from target raise

Evidence & confidence

Target increase suggests bullish view but no new catalyst.

$BULLBearishMedium confidence
Context

Rosenblatt cut price target to $12, signaling downside risk.

Expected impact

likely downward pressure

Evidence & confidence

Analyst downgrade may prompt sell interest.

$ALGNBearishMedium confidence
Context

Stifel lowered price target to $175 from $210.

Expected impact

potential price decline

Evidence & confidence

Target cut reflects weaker outlook.

$PCRXNeutralLow confidence
Context

HC Wainwright cut target to $36.5 and downgraded to Neutral.

Expected impact

limited movement, possible slight dip

Evidence & confidence

Minor downgrade without major catalyst.

$SAILBullishLow confidence
Context

Cantor Fitzgerald raised target to $27 from $25.

Expected impact

modest upside potential

Evidence & confidence

Small target increase.

$UBullishLow confidence
Context

BTIG lifted target to $53 from $51.

Expected impact

possible slight rise

Evidence & confidence

Minor target bump.

$CRWDBullishMedium confidence
Context

Needham raised CrowdStrike target to $310 from $250.

Expected impact

likely upward pressure

Evidence & confidence

Significant target increase reflects optimism.

$HUMBullishMedium confidence
Context

Baird increased target to $596 from $390 and upgraded to Outperform.

Expected impact

potential strong upside

Evidence & confidence

Large target jump and upgrade.

Market effects

Analyst target revisions may affect broader tech and consumer discretionary sentiment.

U.S. market focus; limited regional effect.

Minor global relevance, primarily U.S. equities.

Counterpoint

Target cuts may be overblown; price may hold above new targets.

Key entities

  • Morgan Stanley

    Raised HOOD target.

  • Needham

    Raised CRWD target.

Related articles

$HUMHighAI 9/10

Humana (HUM) Stock Hits New 52-Week High

Humana (HUM) reached a new 52-week high after reporting Q3 2026 earnings with a smaller loss and raised full-year EPS guidance. Competitors like CVS Health and Elevance Health also saw gains. Clover Health (CLOV) reported Q3 2026 earnings with a slight profit and raised full-year targets.

$UNHHighAI 8/10

Positive Medicaid signals, open enrollment trends: Recapping major payers' Q3 results

UnitedHealth Group reported Q3 profit of $4.1B (up from $2.3B YoY) and revenue of $112.7B. CVS Health earned $2.2B (up from a $4B loss YoY) on $108.4B revenue, announcing a split of its pharmacy business. Cigna and Elevance Health each posted $1.4B profit. Centene reduced losses to $71M (from $6.6B YoY) on $50.6B revenue. Humana saw $162M profit (down from $195M) on $41.15B revenue, with positive Medicare enrollment trends.

$COINMed

Kentucky Takes Aim at Kalshi, Robinhood, and Coinbase With Triple-Damages Lawsuit

Kentucky Attorney General Russell Coleman sued Kalshi, Coinbase, Robinhood, Webull, and Polymarket, alleging they operated unlicensed sportsbooks. The state claims 89% of Kalshi's $23B 2025 contract volume involved sports wagering. The lawsuits seek triple damages under Kentucky's Loss Recovery Act, with potential penalties up to $10,000 per senior citizen misled. The CFTC also filed a complaint to block these actions.